Price T Rowe Associates Inc. MD trimmed its stake in shares of Endava plc (NYSE:DAVA - Free Report) by 79.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 187,835 shares of the company's stock after selling 744,416 shares during the period. Price T Rowe Associates Inc. MD owned about 0.32% of Endava worth $5,805,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also recently made changes to their positions in DAVA. GAMMA Investing LLC boosted its position in Endava by 86.4% during the fourth quarter. GAMMA Investing LLC now owns 1,607 shares of the company's stock worth $50,000 after acquiring an additional 745 shares during the last quarter. SG Americas Securities LLC increased its holdings in Endava by 1,299.1% in the 4th quarter. SG Americas Securities LLC now owns 430,366 shares of the company's stock valued at $13,298,000 after purchasing an additional 399,605 shares during the last quarter. Janney Montgomery Scott LLC purchased a new position in Endava during the 4th quarter valued at about $783,000. AEGON ASSET MANAGEMENT UK Plc boosted its stake in shares of Endava by 35.3% in the fourth quarter. AEGON ASSET MANAGEMENT UK Plc now owns 332,642 shares of the company's stock valued at $10,282,000 after purchasing an additional 86,870 shares during the period. Finally, Blue Trust Inc. increased its position in shares of Endava by 28.5% during the fourth quarter. Blue Trust Inc. now owns 1,494 shares of the company's stock worth $46,000 after acquiring an additional 331 shares during the period. 62.23% of the stock is currently owned by institutional investors and hedge funds.
Endava Stock Performance
NYSE DAVA traded up $0.11 during trading hours on Friday, hitting $20.05. 147,219 shares of the stock were exchanged, compared to its average volume of 485,720. The company has a quick ratio of 1.90, a current ratio of 1.90 and a debt-to-equity ratio of 0.21. The company has a market cap of $1.18 billion, a price-to-earnings ratio of 182.27, a price-to-earnings-growth ratio of 2.26 and a beta of 1.25. Endava plc has a 12-month low of $16.60 and a 12-month high of $34.94. The stock has a 50-day moving average of $19.55 and a 200 day moving average of $26.01.
Endava (NYSE:DAVA - Get Free Report) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.32 by ($0.18). Endava had a return on equity of 0.89% and a net margin of 0.74%. The business had revenue of $250.63 million for the quarter, compared to analyst estimates of $197.33 million. As a group, equities research analysts forecast that Endava plc will post 0.57 earnings per share for the current year.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on the stock. Morgan Stanley raised their price objective on shares of Endava from $33.00 to $35.00 and gave the company an "equal weight" rating in a report on Friday, January 31st. Susquehanna lowered their price objective on Endava from $55.00 to $50.00 and set a "positive" rating for the company in a research report on Friday, February 21st. Finally, Needham & Company LLC decreased their target price on Endava from $43.00 to $38.00 and set a "buy" rating for the company in a research note on Friday, February 21st. Four investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, Endava currently has a consensus rating of "Moderate Buy" and an average price target of $38.51.
Get Our Latest Analysis on Endava
About Endava
(
Free Report)
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
Further Reading

Before you consider Endava, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.
While Endava currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.